Table 3.
Clinical trial | MT | BMT | MT | BMT |
---|---|---|---|---|
MR CLEAN | 115/196 (59%) | N/A | 141/187 (75%)a | 68/207 (33%)a |
ESCAPE | 113/156 (72%) | N/A | N/A | N/A |
EXTEND‐IA | 25/29 (86%) | N/A | 33/35 (94%)a | 15/35 (43%)a |
SWIFT PRIME | 73/83 (88%) | N/A | 53/64 (83%)b | 21/52 (40%)b |
REVASCAT | 67/102 (66%) | N/A | N/A | N/A |
MT, mechanical thrombectomy; BMT, best medical therapy; N/A, not applicable.
Recanalization shown in brain CTA/MRA at 24 h.
Reperfusion shown in brain CT perfusion/MR perfusion at 27 h.